Published in: The Business Standard Date: 9 Apr 2021 Enough vaccines have now been administered to fully vaccinate about 5% of the global population — but […]
Published in: The Business Standard Date: 7 Apr 2021 The Covid-19 pandemic has revealed the devastating and deadly shortcomings of current global health cooperation and governance, […]
Published in: The Business Standard Date: 6 Apr 2021 A frightening second wave of Covid-19 has begun to sweep over the world’s second-biggest nation. Case numbers […]
Published in: The Business Standard Date: 31 March, 2021 Germany’s federal and state health ministries agreed that under 60-year-olds should only receive the AstraZeneca vaccine […]
Published in: The Business Standard Date: 31 Mar 2021 By just about every measure other than mortality (which is pretty important!), the Covid-19 pandemic has been harder on […]
Published in: The Business Standard Date: 30 March, 2021 Canada following fears that the Oxford/AstraZeneca Covid-19 vaccine could be related to unusual blood clots suspended […]
Published in: The Daily Star Date: 30 March, 2021 Reuters, Ottawa/ Toronto Canadian health officials said on Monday they would stop offering AstraZeneca’s Covid-19 vaccine to […]
Published in: The Business Standard Date: 27 March, 2021 Pfizer is currently authorized for use starting at age 16; Moderna is for people 18 and older […]
Published in: The Daily Star Date: 27 March, 2021 Serum Institute of India CEO Adar Poonawalla today tweeted that the trial for their second Covid-19 […]